TAK ALG-12.5 (Alogliptin benzoate 12.5 mg)
Pill imprint TAK ALG-12.5 has been identified as Alogliptin benzoate 12.5 mg.
Alogliptin is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Alogliptin 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
Alogliptin benzoate
- Imprint:
- TAK ALG-12.5
- Strength:
- 12.5 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Perrigo New York Inc.
More about alogliptin
Consumer resources
- Other brands: Nesina
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
